STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

LevelJump Announces 2024 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
LevelJump Healthcare Corp. reported strong financial results for 2024, with revenues reaching $17.7 million, representing a 41% increase from $12.6 million in 2023. The company's Q4 2024 revenue was $4.8 million with a net profit of $1.95 million, while the full-year net profit stood at $1.2 million. Canadian Teleradiology Services, their wholly-owned subsidiary, achieved EBITDA of $3.35 million. The company reported full-year EBITDA of $1.54 million, with Q4 EBITDA at $395,936. LevelJump is currently interpreting imaging scans for approximately 200,000 patients annually. Post year-end, the company announced plans to acquire two diagnostic imaging outpatient clinics in Calgary, Alberta, with the transaction expected to close by July 2025.
LevelJump Healthcare Corp. ha riportato risultati finanziari solidi per il 2024, con ricavi pari a 17,7 milioni di dollari, segnando un aumento del 41% rispetto ai 12,6 milioni di dollari del 2023. Nel quarto trimestre 2024, i ricavi sono stati di 4,8 milioni di dollari con un utile netto di 1,95 milioni di dollari, mentre l'utile netto annuale si è attestato a 1,2 milioni di dollari. La controllata interamente posseduta, Canadian Teleradiology Services, ha raggiunto un EBITDA di 3,35 milioni di dollari. L'EBITDA annuale della società è stato di 1,54 milioni di dollari, con un EBITDA nel quarto trimestre pari a 395.936 dollari. LevelJump interpreta attualmente scansioni di imaging per circa 200.000 pazienti all'anno. Dopo la chiusura dell'esercizio, l'azienda ha annunciato l'intenzione di acquisire due cliniche diagnostiche di imaging ambulatoriale a Calgary, Alberta, con la transazione prevista per la conclusione entro luglio 2025.
LevelJump Healthcare Corp. reportó sólidos resultados financieros para 2024, con ingresos que alcanzaron los 17,7 millones de dólares, lo que representa un aumento del 41% respecto a los 12,6 millones de dólares en 2023. Los ingresos del cuarto trimestre de 2024 fueron de 4,8 millones de dólares con una ganancia neta de 1,95 millones de dólares, mientras que la ganancia neta anual fue de 1,2 millones de dólares. Canadian Teleradiology Services, su subsidiaria de propiedad total, logró un EBITDA de 3,35 millones de dólares. La compañía reportó un EBITDA anual de 1,54 millones de dólares, con un EBITDA del cuarto trimestre de 395.936 dólares. LevelJump actualmente interpreta escaneos de imágenes para aproximadamente 200.000 pacientes al año. Después del cierre del año, la empresa anunció planes para adquirir dos clínicas ambulatorias de diagnóstico por imagen en Calgary, Alberta, con la transacción prevista para completarse en julio de 2025.
LevelJump Healthcare Corp.는 2024년에 강력한 재무 실적을 보고했으며, 매출은 1,770만 달러로 2023년 1,260만 달러 대비 41% 증가했습니다. 2024년 4분기 매출은 480만 달러, 순이익은 195만 달러였으며, 연간 순이익은 120만 달러였습니다. 완전 자회사인 Canadian Teleradiology Services는 335만 달러의 EBITDA를 기록했습니다. 회사의 연간 EBITDA는 154만 달러였고, 4분기 EBITDA는 39만 5,936달러였습니다. LevelJump는 현재 연간 약 20만 명의 환자에 대해 영상 스캔을 판독하고 있습니다. 연도 말 이후, 회사는 앨버타 주 캘거리에서 두 개의 진단 영상 외래 클리닉 인수를 계획하고 있으며, 거래는 2025년 7월까지 완료될 예정입니다.
LevelJump Healthcare Corp. a annoncé de solides résultats financiers pour 2024, avec un chiffre d'affaires atteignant 17,7 millions de dollars, soit une augmentation de 41 % par rapport à 12,6 millions de dollars en 2023. Le chiffre d'affaires du quatrième trimestre 2024 s'est élevé à 4,8 millions de dollars avec un bénéfice net de 1,95 million de dollars, tandis que le bénéfice net annuel s'est établi à 1,2 million de dollars. Canadian Teleradiology Services, leur filiale détenue à 100 %, a réalisé un EBITDA de 3,35 millions de dollars. L'EBITDA annuel de la société s'est élevé à 1,54 million de dollars, avec un EBITDA au quatrième trimestre de 395 936 dollars. LevelJump interprète actuellement des examens d'imagerie pour environ 200 000 patients par an. Après la clôture de l'exercice, la société a annoncé son intention d'acquérir deux cliniques d'imagerie diagnostique en ambulatoire à Calgary, Alberta, la transaction devant être finalisée d'ici juillet 2025.
LevelJump Healthcare Corp. meldete starke Finanzergebnisse für 2024 mit einem Umsatz von 17,7 Millionen US-Dollar, was einem Anstieg von 41 % gegenüber 12,6 Millionen US-Dollar im Jahr 2023 entspricht. Der Umsatz im vierten Quartal 2024 betrug 4,8 Millionen US-Dollar bei einem Nettogewinn von 1,95 Millionen US-Dollar, während der Jahresnettogewinn bei 1,2 Millionen US-Dollar lag. Die vollständig im Besitz befindliche Tochtergesellschaft Canadian Teleradiology Services erzielte ein EBITDA von 3,35 Millionen US-Dollar. Das Unternehmen meldete ein Jahres-EBITDA von 1,54 Millionen US-Dollar, mit einem EBITDA im vierten Quartal von 395.936 US-Dollar. LevelJump interpretiert derzeit Bildgebungsscans für etwa 200.000 Patienten jährlich. Nach Jahresende kündigte das Unternehmen Pläne an, zwei ambulante diagnostische Bildgebungszentren in Calgary, Alberta, zu übernehmen, wobei der Abschluss der Transaktion bis Juli 2025 erwartet wird.
Positive
  • Revenue increased 41% year-over-year to $17.7 million in 2024
  • Achieved net profit of $1.2 million for full year 2024
  • Strong Q4 2024 performance with $1.95 million net profit
  • Canadian Teleradiology Services subsidiary generated $3.35 million in EBITDA
  • Company serves approximately 200,000 patients annually
  • Expansion plans include acquisition of two diagnostic imaging clinics in Calgary
Negative
  • None.

Toronto, Ontario--(Newsfile Corp. - June 20, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the year ended December 31, 2024.

Financial and Operational Highlights

  • Revenues were $17.7 million in 2024 compared to $12.6 million in revenues for 2023, a year over year revenue increase of 41%.

  • Canadian Teleradiology Services, Inc., the Company's 100% owned subsidiary had EBITDA for 2024 of $3.35 million.

2024 Financial Results for fourth quarter and year

  • Revenues of $4.8 million in Q4 2024 and $17.7 million for the year 2024 with a net profit of $1.95 million for Q4 2024 and a net profit of $1.2 million for the year 2024.

  • EBITDA of $395,936 for Q4 2024 and $1,545,298 for the year 2024.

Subsequent Events

Subsequent to the year end, the Company entered an agreement to acquire two additional diagnostic imaging outpatient clinic locations in Calgary, Alberta. The transaction is expected to close towards the end of July 2025. See the Company's news release dated June 13, 2025.

Management Comments

"2024 was a transformative year for our Company, marked by significant growth, particularly within our clinic operations," said Mitch Geisler, CEO. "Our year-over-year revenue increased by more than 40%, and we achieved strong EBITDA performance. We are now interpreting imaging scans for approximately 200,000 patients annually across all operations. Our focus remains on driving organic growth and advancing our long-term vision for continued expansion."

Non-IFRS Financial Measures

This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity.

For further details on the results, please refer to LevelJump's Management, Discussion and Analysis and Consolidated Financial Statements for the year ended December 31, 2024, which are available on the Company's website (www.leveljumphealthcare.com) and under the Company's profile on SEDAR+ (www.sedarplus.ca).

About LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler
Chief Executive Officer
info@leveljumphealthcare.com
647-340-2020

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/256361

FAQ

What was LevelJump Healthcare's (JMPHF) revenue growth in 2024?

LevelJump Healthcare reported revenue growth of 41%, increasing from $12.6 million in 2023 to $17.7 million in 2024.

How much profit did LevelJump Healthcare (JMPHF) make in Q4 2024?

LevelJump Healthcare made a net profit of $1.95 million in Q4 2024.

What is LevelJump Healthcare's (JMPHF) annual patient volume?

LevelJump Healthcare interprets imaging scans for approximately 200,000 patients annually across all operations.

What expansion plans does LevelJump Healthcare (JMPHF) have for 2025?

LevelJump Healthcare has entered an agreement to acquire two diagnostic imaging outpatient clinic locations in Calgary, Alberta, with the transaction expected to close by July 2025.

What was LevelJump Healthcare's (JMPHF) EBITDA for 2024?

LevelJump Healthcare reported an EBITDA of $1,545,298 for the full year 2024.
Leveljump Health

OTC:JMPHF

JMPHF Rankings

JMPHF Latest News

JMPHF Stock Data

3.48M
70.88M
26.53%
Diagnostics & Research
Healthcare
Link
Canada
Toronto